Sektor Northwest Biotherapeutics, Inc.

Aktien

A1J5EY

US66737P6007

NWBO

Biotechnologie

Markt geschlossen - 21:59:53 04.06.2026 Perf. 5 T Veränd. 1. Jan.
0.2050 USD +0.49% Intraday Chart für Northwest Biotherapeutics, Inc. +20.59% -10.38%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+0.49%+20.59%+38.51%+11.66%-10.38%-15.95%-77.16%-81.53%-54.20% 297 Mio.
+2.24%+5.83%-7.23%-2.93%+65.81%+58.47%+65.65%+22.29% - 66.7 Mrd.
+4.66%+5.77%+21.00%+11.87%+19.11%+16.93%+82.87%+212.06%+6’373.09% 56.88 Mrd.
-0.60%+2.36%+17.04%+15.24%+22.61%+24.32%+97.19%-7.75%+264.51% 56.53 Mrd.
+2.55%+12.69%+19.19%+19.83%+37.37%+30.43%+108.45%+19.29%+1’180.15% 46.49 Mrd.
+2.58%+4.31%+7.71%+16.82%+23.70%+32.49%+39.59%+10.87%+267.18% 44.8 Mrd.
+4.09%+4.62%+6.39%-2.44%+151.29%+228.06%+845.00%+511.52% - 41.59 Mrd.
-0.47%+9.60%+16.93%+5.37%+21.82%+27.53%+52.88%+29.66%+176.96% 35.35 Mrd.
+3.80%-6.42%+55.39%+83.14%+80.61%+98.16%+68.09%+21.63%+211.84% 33.29 Mrd.
+1.48%+3.13%+15.55%-11.44%-33.29%-38.80%+388.84%+253.64%+858.71% 25.1 Mrd.
+2.73%+9.98%-9.57%+6.67%+55.60%+44.82%-4.08%-47.45% - 24.92 Mrd.
0.00%-0.75%-4.94%-6.58%-8.08%-15.15%-12.16%-63.93% - 21.7 Mrd.
+3.03%+3.21%+11.65%+13.93%+19.81%+14.22%+144.37%+199.67%+1’986.60% 18.27 Mrd.
+3.12%+3.39%+21.55%+32.68%+63.68%+75.79%+245.90%+282.41%+475.30% 16.98 Mrd.
-1.58%-0.55%+15.24%+24.99%+39.81%+49.69%+71.19%-14.65%+116.21% 16.88 Mrd.
+1.18%+3.41%+16.69%+1.74% - - - - - 16.87 Mrd.
+4.69%-1.69%+18.57%+32.09%+77.13%+110.26%+100.80%-5.49%+390.07% 16.17 Mrd.
+7.87%+15.13%+14.64%+10.48%+223.34%+203.34%+353.96%+1’620.89%+872.03% 16.05 Mrd.
+1.39%-1.78%+26.19%+26.19%+13.92%+30.44%-19.54%-22.56%+166.24% 15.34 Mrd.
+11.03%+16.92%+21.88%+62.23%+43.00%+18.00% - - - 13.87 Mrd.
Durchschnitt +2.68%+2.38%+16.12%+17.58%+47.73%+52.27%+141.77%+163.36%+948.91% 29 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +2.55%+3.34%+13.76%+15.11%+48.36%+54.29%+153.75%+135.70%+1’376.26%
  1. Börse
  2. Aktien
  3. A1J5EY Aktie
  4. Sektor Northwest Biotherapeutics, Inc.